Identifying Ultrasound Markers for Down Syndrome

Area of Science:

• Maternal-Fetal Medicine
• Prenatal Diagnostics
• Genetics

Background:

• Maternal age is a known risk factor for Down syndrome (trisomy 21).
• Current screening methods, including maternal age and biochemical markers (triple-screen test), have limitations in detection rates.
• Ultrasound evaluation is increasingly utilized for prenatal screening of chromosomal anomalies.

Purpose of the Study:

• To evaluate the effectiveness of ultrasound as a screening tool for fetal Down syndrome.
• To identify specific ultrasound markers associated with trisomy 21.
• To assess the potential of ultrasound to reduce the need for invasive diagnostic procedures.

Main Methods:

• Review of ultrasound findings in fetuses with chromosomal defects.
• Categorization of ultrasound markers into major malformations and specific screening indicators for Down syndrome.
• Comparison of ultrasound screening with traditional methods like maternal age and triple-screen tests.

Main Results:

• Ultrasound can identify anatomical characteristics in 11% to 35% of fetuses with chromosomal defects.
• Specific ultrasound indicators for Down syndrome include brachycephaly, nuchal edema, and echogenic bowel.
• Combined use of ultrasound and biochemical markers enhances Down syndrome screening sensitivity.

Conclusions:

• Detailed ultrasound evaluation is a valuable screening tool for fetal Down syndrome.
• Specific ultrasound markers can aid in identifying fetuses at higher risk for trisomy 21.
• Improved prenatal screening with ultrasound may lead to more accurate genetic counseling and fewer invasive tests.